Tremor

JAMA

Volumn 311, Issue 9, 2014, Pages 948-954

  Elias, W Jeffrey ^a   Shah, Binit B ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA; LEVODOPA; LITHIUM SALT; PRAMIPEXOLE; PROPRANOLOL; VALPROIC ACID;

ANAMNESIS; BRAIN DEPTH STIMULATION; CLINICAL EVALUATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ESSENTIAL TREMOR; HUMAN; NEUROIMAGING; NEUROPATHOLOGY; PARKINSON DISEASE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; STEREOTACTIC BODY RADIATION THERAPY; THALAMOTOMY; TREMOR;

AGED; AGED, 80 AND OVER; ESSENTIAL TREMOR; HUMANS; MALE; PARKINSON DISEASE; TREMOR;

EID: 84895442439     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.1397     Document Type: Review

References (60)

1. Fahn S, Oakes D, Shoulson I, et al Parkinson Study Group. Levodopa and the progression of Parkinson's disease. N Engl J Med. 2004;351(24):2498-2508.
2. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. JAMA. 2000;284(15):1931-1938.
3. Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol. 1989;46(10):1052-1060.
4. Louis ED, Ferreira JJ. How common is the most common adultmovement disorder? update on the worldwide prevalence of essential tremor. Mov Disord. 2010;25(5):534-541.
5. Louis ED, Ottman R, Hauser WA. How common is the most common adultmovement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998;13(1):5-10.
6. de Rijk MC, Breteler MM, Graveland GA, et al. Prevalence of Parkinson's disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143-2146.
7. de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-535.
8. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain. 1994;117(pt 4):805-824. (Pubitemid 24281842)
9. Rajput A, Robinson CA, Rajput AH. Essential tremor course and disability: a clinicopathologic study of 20 cases. Neurology. 2004;62(6): 932-936. (Pubitemid 38435781)
10. Brin MF, KollerW. Epidemiology and genetics of essential tremor. Mov Disord. 1998;13(suppl 3): 55-63. (Pubitemid 28517760)
11. Louis ED, Barnes L, Albert SM, et al. Correlates of functional disability in essential tremor. Mov Disord. 2001;16(5):914-920. (Pubitemid 36041194)
12. Louis ED, Ford B, Barnes LF. Clinical subtypes of essential tremor. Arch Neurol. 2000;57(8):1194-1198. (Pubitemid 30644668)
13. Lorenz D, Schwieger D, Moises H, Deuschl G. Quality of life and personality in essential tremor patients. Mov Disord. 2006;21(8):1114-1118. (Pubitemid 44336594)
14. Woods SP, Scott JC, Fields JA, Poquette A, Tröster AI. Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor. Cogn Behav Neurol. 2008;21(1):28-33. (Pubitemid 351355039)
15. Schneier FR, Barnes LF, Albert SM, Louis ED. Characteristics of social phobia among persons with essential tremor. J Clin Psychiatry. 2001;62(5):367-372. (Pubitemid 32545560)
16. Deuschl G, Bain P, Brin M; Ad Hoc Scientific Committee. Consensus statement of the Movement Disorder Society on tremor. Mov Disord. 1998;13(suppl 3):2-23. (Pubitemid 28517753)
17. Shah BS. Diagnosing Parkinson's disease. In: Hawley J, Weiner W, eds. Parkinson's Disease: Improving Patient Care. New York, NY: Oxford University Press; 2013.
18. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Parkinson Disease and Movment Disorders. Baltimore, MD: Williams & Wilkins; 1993;271-280.
19. Raethjen J, Pawlas F, Lindemann M, Wenzelburger R, Deuschl G. Determinants of physiologic tremor in a large normal population. Clin Neurophysiol. 2000;111(10):1825-1837.
20. LombardiWJ,Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. Neurology. 2001;57(5):785-790. (Pubitemid 32845495)
21. Parisi SL, Héroux ME, Culham EG, Norman KE. Functional mobility and postural control in essential tremor. Arch Phys Med Rehabil. 2006;87(10):1357-1364. (Pubitemid 44470764)
22. Stolze H, Petersen G, Raethjen J,Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain. 2001;124(pt 11):2278-2286. (Pubitemid 33055371)
23. Bove M, Marinelli L, Avanzino L, Marchese R, Abbruzzese G. Posturographic analysis of balance control in patients with essential tremor. Mov Disord. 2006;21(2):192-198.
24. Tanner CM, Goldman SM, Lyons KE, et al. Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology. 2001;57(8):1389-1391. (Pubitemid 32995717)
25. Brodkey JA, Tasker RR, Hamani C, McAndrews MP, Dostrovsky JO, Lozano AM. Tremor cells in the human thalamus: differences among neurological disorders. J Neurosurg. 2004;101(1):43-47. (Pubitemid 38808459)
26. Jenkins IH, Bain PG, Colebatch JG, et al. A positron emission tomography study of essential tremor: evidence for overactivity of cerebellar connections. Ann Neurol. 1993;34(1):82-90. (Pubitemid 23188731)
27. Berg D, Preibisch C, Hofmann E, Naumann M. Cerebral activation pattern in primary writing tremor. J Neurol Neurosurg Psychiatry. 2000;69(6):780-786.
28. Nicoletti G, Manners D, Novellino F, et al. Diffusion tensor MRI changes in cerebellar structures of patients with familial essential tremor. Neurology. 2010;74(12):988-994.
29. Louis ED, Shungu DC, Chan S, Mao X, Jurewicz EC,Watner D. Metabolic abnormality in the cerebellum in patients with essential tremor: a proton magnetic resonance spectroscopic imaging study. Neurosci Lett. 2002;333(1):17-20. (Pubitemid 35223592)
30. Rajput AH, Robinson CA, Rajput ML, Robinson SL, Rajput A. Essential tremor is not dependent upon cerebellar Purkinje cell loss. Parkinsonism Relat Disord. 2012;18(5):626-628.
31. Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology. 2008;70(16 pt 2):1452-1455. (Pubitemid 351521939)
32. Yu M, Ma K, Faust PL, et al. Increased number of Purkinje cell dendritic swellings in essential tremor. Eur J Neurol. 2012;19(4):625-630.
33. Riederer P,Wuketich S. Time course of nigrostriatal degeneration in Parkinson's disease: a detailed study of influential factors in human brain amine analysis. J Neural Transm. 1976;38(3-4): 277-301.
34. Rodriguez-Oroz MC, Obeso JA, Lang AE, et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up. Brain. 2005;128(pt 10):2240-2249. (Pubitemid 41407964)
35. Jankovic J, McDermottM, Carter J, et al; Parkinson Study Group. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. Neurology. 1990;40(10):1529-1534.
36. Rajput AH, Voll A, Rajput ML, Robinson CA, Rajput A. Course in Parkinson disease subtypes: a 39-year clinicopathologic study. Neurology. 2009;73(3):206-212.
37. Alves G, Larsen JP, EmreM,Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord. 2006;21(8):1123-1130. (Pubitemid 44336596)
38. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders, part 1: baseline and 3-month observations. Mov Disord. 2003;18(9):977-984. (Pubitemid 37185204)
39. Eidelberg D, Moeller JR, Ishikawa T, et al. Early differential diagnosis of Parkinson's disease with 18F-fluorodeoxyglucose and positron emission tomography. Neurology. 1995;45(11):1995-2004.
40. Deuschl G, Raethjen J, Baron R, Lindemann M, Wilms H, Krack P. The pathophysiology of parkinsonian tremor: a review. J Neurol. 2000;247(suppl 5):V33-V48.
41. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol. 1993;50(2):140-148. (Pubitemid 23054795)
42. Bartels AL, Leenders KL. Parkinson's disease: the syndrome, the pathogenesis and pathophysiology. Cortex. 2009;45(8):915-921.
43. Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord. 2007;13(2):67-76. (Pubitemid 46329516)
44. Fasano A, Bove F, Lang AE. The treatment of dystonic tremor: a systematic review. J Neurol Neurosurg Psychiatry. 2013.
45. General overview of psychogenic movement disorders: epidemiology, diagnosis, and prognosis. In: Hallett SF, Jankovic J, Lang AE, Cloninger CR, Yudofsky SC, eds. Psychogenic Movement Disorders - Neurology and Neuropsychiatry. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:35-41.
46. KollerW, Lang A, Vetere-Overfield B, et al. Psychogenic tremors. Neurology. 1989;39(8):1094-1099. (Pubitemid 19217480)
47. Zesiewicz TA, Elble R, Louis ED, et al Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: therapies for essential tremor: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2005;64(12):2008-2020. (Pubitemid 40880986)
48. KollerWC, Vetere-Overfield B. Acute and chronic effects of propranolol and primidone in essential tremor. Neurology. 1989;39(12):1587-1588. (Pubitemid 20013592)
49. Diaz NL, Louis ED. Survey of medication usage patterns among essential tremor patients: movement disorder specialists vs general neurologists. Parkinsonism Relat Disord. 2010;16(9):604-607.
50. Zesiewicz TA, Elble RJ, Louis ED, et al. Evidence-based guideline update: treatment of essential tremor: report of the Quality Standards subcommittee of the American Academy of Neurology. Neurology. 2011;77(19):1752-1755.
51. Holloway RG, Shoulson I, Fahn S, et al Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol. 2004;61(7):1044-1053. (Pubitemid 38915945)
52. Schelosky L, Benke T, PoeweW. Lack of selective vulnerability to anticholinergic induced cognitive impairment in early Parkinson's disease. Behav Neurol. 1991;4(2):103-111.
53. Bucy PC, Case TJ. Tremor: physiologic mechanism and abolition by surgical means. Arch Neurol Psychiatry. 1939;41(4):721-746.
54. Pahwa R, Lyons KE,Wilkinson SB, et al. Comparison of thalamotomy to deep brain stimulation of the thalamus in essential tremor. Mov Disord. 2001;16(1):140-143. (Pubitemid 36041129)
55. Schuurman PR, Bosch DA, Bossuyt PM, et al. A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med. 2000;342(7):461-468. (Pubitemid 30100233)
56. Tasker RR. Deep brain stimulation is preferable to thalamotomy for tremor suppression. Surg Neurol. 1998;49(2):145-154. (Pubitemid 28068419)
57. Anderson VC, Burchiel KJ, HartMJ, Berk C, Lou JS. A randomized comparison of thalamic stimulation and lesion on self-paced finger movement in essential tremor. Neurosci Lett. 2009;462(2):166-170.
58. Young RF, Li F, Vermeulen S, Meier R. Gamma knife thalamotomy for treatment of essential tremor: long-term results. J Neurosurg. 2010;112(6):1311-1317.
59. Kooshkabadi A, Lunsford LD, Tonetti D, Flickinger JC, Kondziolka D. Gamma knife thalamotomy for tremor in the magnetic resonance imaging era. J Neurosurg. 2013;118(4):713-718.
60. EliasWJ, Huss D, Voss T, et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med. 2013;369(7):640-648.